Our portfolio companies

Portfolio Our portfolio companies

Curetis

Curetis

Simple and rapid solutions for the diagnosis of severe infectious diseases in hospitalized patients.

Curetis AG is a molecular diagnostic company focusing on the development and commercialization of a universal molecular diagnostics solution for easy-to-use, fast and reliable molecular disease testing. Curetis N.V. completed its IPO on November 11, 2015, in Amsterdam raising EUR 44 million.

  • Industry Diagnostics